These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 13091943)

  • 1. [Chemotherapy of tuberculosis with p-aminosalicylic acid; experimental studies on PAS and sodium-PAS blood level after administration].
    KOELZER PP; WEHR KH; GIESEN J
    Arztl Forsch; 1953 Jul; 7(7):I/336-44. PubMed ID: 13091943
    [No Abstract]   [Full Text] [Related]  

  • 2. [On PAS calcium salts].
    SMOLAREK W
    Tuberkulosearzt; 1953 May; 7(5):303-5. PubMed ID: 13090340
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic evaluation of para-aminosalicylic acid granules.
    Peloquin CA; Henshaw TL; Huitt GA; Berning SE; Nitta AT; James GT
    Pharmacotherapy; 1994; 14(1):40-6. PubMed ID: 8159600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PAS concentration in blood in therapeutic use of PAS and its salts].
    NILSSON H
    Sven Lakartidn; 1952 Apr; 49(16):1044-50. PubMed ID: 14958642
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of blood levels of para-aminosalicylic acid (PAS) in tuberculous patients treated with various PAS preparations.
    BANG HO; STRANDGAARD E
    Acta Tuberc Scand; 1957; 34(1-2):58-75. PubMed ID: 13508356
    [No Abstract]   [Full Text] [Related]  

  • 6. A micro-method for the determination of paraaminosalicylic acid (aminosallyl) PAS and n-acetyl-para-aminosalicylic acid (acetyl-PAS).
    NIELSEN E; PRAETORIUS E
    Scand J Clin Lab Invest; 1952; 4(4):313-8. PubMed ID: 13048610
    [No Abstract]   [Full Text] [Related]  

  • 7. [Para-aminosalicylic acid and streptomycin blood level in renal tuberculosis].
    HOESS H; LAUENER H; SCHONHOLZER G
    Urol Int; 1956; 3(2-3):114-21. PubMed ID: 13401594
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of PAS on blood picture in tuberculosis].
    PARAF J; DESBORDES J; ZIVY P
    Sang; 1952; 23(7):616-8. PubMed ID: 13004917
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of blood and cerebrospinal fluid levels of para-aminosalicylic acid in children affected with meningeal tuberculosis, with special reference to the blood-spinal fluid quotient].
    VIGNOLO-LUTATI U; GAMALERO PC
    Minerva Pediatr; 1953 Apr; 5(7):241-5. PubMed ID: 13072133
    [No Abstract]   [Full Text] [Related]  

  • 10. Para-aminosalicylic-acid (PAS) concentrations in the serum during treatment with various PAS preparations.
    CITRON KM; KUPER SW
    Tubercle; 1959 Dec; 40():443-52. PubMed ID: 13693755
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance.
    Adams KT; Donald PR; Abulfathi AA; Diacon AH; Stander MA; Reuter H
    J Clin Pharmacol; 2020 Apr; 60(4):489-494. PubMed ID: 31682027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative concentration of PAS in blood following oral administration of PAS alone and with vitamin C].
    NEDELJKOVIC J; DUGANDZIC S; DUGANDZIC M; TUCAKOVIC M
    Vojnosanit Pregl; 1954; 11(9-10):372-6. PubMed ID: 13226731
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma concentrations of para-aminosalicylic acid (PAS) after oral and rectal administration as influenced by p-(di-n-propylsulfamyl)-benzoic acid (benemid).
    RIEBER CW; SALINE M; FRIEDMAN MM
    Am Rev Tuberc; 1951 Oct; 64(4):448-52. PubMed ID: 14885675
    [No Abstract]   [Full Text] [Related]  

  • 14. The concentration of PAS in the blood during medication with PAS or PAS-salts.
    NILSSON H
    Tubercle; 1953 Apr; 34(4):100-4. PubMed ID: 13049572
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum isoniazid concentrations in Japanese tuberculosis patients and the effect of the simultaneous administration of PAS.
    REI TS
    Jpn J Microbiol; 1960 Jan; 4():1-6. PubMed ID: 13740408
    [No Abstract]   [Full Text] [Related]  

  • 16. 4-Aminosalicylic acid blood levels following oral administration of sodium 4-aminosalicylate and calcium 4-benzamidosalicylate.
    DRAIN DJ; LAZARE R; TATTERSALL K
    Tubercle; 1959 Jun; 40():201-4. PubMed ID: 13817982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral administration of PAS].
    RENARD J; COULET M; RIMBAULT Y
    Therapie; 1952; 7(4):362-7. PubMed ID: 12984373
    [No Abstract]   [Full Text] [Related]  

  • 18. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
    Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
    Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PAS blood content after peroral intake of different calcium-PAS-granulates].
    SANZ MC; MULLER A
    Schweiz Med Wochenschr; 1952 Dec; 82(52):1334-5. PubMed ID: 13028219
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical pharmacokinetics of para-aminosalicylic acid tablets].
    Miroshnichenko II; Sokolova GB; Mokhireva LV
    Antibiot Khimioter; 2009; 54(1-2):20-4. PubMed ID: 19499713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.